Literature DB >> 17964919

Bariatric surgery for morbid obesity--a cure for metabolic syndrome?

Subhash Kini1, Daniel M Herron, Robert T Yanagisawa.   

Abstract

At present there is no single medication that targets the metabolic syndrome directly. Bariatric surgery, a treatment option for morbidly obese individuals who fail medical therapy, has been shown to be very effective in treating multiple aspects of the metabolic syndrome. The decrease in insulin resistance is because of significant weight loss and by enhancing secretion of gut hormones such as glucagon-like peptide-1 (GLP-1).

Entities:  

Mesh:

Year:  2007        PMID: 17964919     DOI: 10.1016/j.mcna.2007.06.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats.

Authors:  Prasanth K Chelikani; Imran H Shah; Esmaeel Taqi; David L Sigalet; Henry H Koopmans
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

2.  Metabolic syndrome and chronic kidney disease.

Authors:  D Bhowmik; S C Tiwari
Journal:  Indian J Nephrol       Date:  2008-01

3.  Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study.

Authors:  Marek Bužga; Pavol Holéczy; Zdeněk Švagera; Pavel Zonča
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-14       Impact factor: 1.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.